DNA news from FierceBioResearcher
News
Scientists in a race to create artificial life forms
U.K. approves 'cybrids' for stem cell research
Ventner team gets clearer picture of full genome
Gene combo dramatically increases risk of Alzheimer's
New work at the Translational Genomics Research Institute in Phoenix has revealed that a copy of the APOE4 gene variant quadruples a person's chances of developing late-onset Alzheimer's. Couple that with the GAB2 variant and the chance of developing the disease rises to 16 times the average risk factor. The scientists believe that the combination of the two spurs the development of one of the proteins that afflicts the brains of people with Alzheimer's. In their work, the scientists …
Read more...Doctor creates vaginal tissue with stem cells
In another example of the effectiveness of stem cells in crafting new tissue, an Italian doctor has successfully used the approach to create healthy vaginal tissue in two women suffering from a rare congenital condition. Dr. Cinzia Marchese said that the first woman was operated on a year ago and now has healthy vaginal tissue where there was none before. The second operation occurred just days ago, with the physician saying that it appeared that the stem cells were growing into new …
Read more...Biomedical researchers lobby against funding cuts
Some of the country's top biomedical researchers have been beating a path to Congress in an attempt to fend off deep cuts in research funds. Nobel Prize winner Roger D. Kornberg, for example, has been making the point that it was doubtful he could have done his groundbreaking work on the way DNA is copied in the current budgetary environment. "In the present climate especially, the funding decisions are ultraconservative," he told The Washington Post. "If the work that you …
Read more...New agent disables genetic diseases
A study to appear in the June 2007 issue of The FASEB Journal describes a new agent, called "Zorro-LNA," which has the potential to stop genetic disorders in their tracks. In the study, researchers from the Karolinska Institute in Stockholm, Sweden, describe how they developed Zorro-LNA to bind with both strands of a gene's DNA simultaneously, effectively disabling that gene. This development has clinical implications for virtually every human condition caused by or worsened by …
Read more...ALSO NOTED: Cloning scientist forecasts new approach to stem cells; Leukemia cell linked to relapse is identified;
Stem Cells
Acclaimed scientist Ian Wilmut told an audience in Connecticut that efforts on embryo cloning--often thwarted by government regulators--may be overtaken by research on reprogramming DNA so that adult stem cells can be used to create new stem cells. Report
NPR reports on state funding for stem cell research, and the …
Read more...Cancer cells much more likely to mutate
Once cells become cancerous they are 100 times more likely to genetically mutate than normal cells, according to researchers. And that conclusion could spell serious trouble for research programs that seek to control a single gene involved in malignancy. "This is very bad news, because it means that cancer cells in a tumor will have mutations that protect them from therapeutics," said lead investigator Lawrence Loeb of the University of Washington School of Medicine. The research also …
Read more...ALSO NOTED: Australia lifts cloning ban; New nanotech sensor developed; Research into tissue regeneration;
More Research
Lawmakers in Australia have lifted a four-year ban on cloning embryonic stem cells for research purposes. Report
Roche and the National Center of Competence in Research at the new Swiss Nanoscience Institute have unveiled new research into a nanotech sensor that can be used to monitor a …
Read more...Paid Research Reports
- Pipeline Insight: Nosocomial Vaccines - Minefield or Goldmine?
- Drug Approval Trends at the FDA and EMEA: Process improvements, heightened scrutiny and industry response
- Biotech 2008 – life sciences industry report (online & print)
- Is there a market for alcoholism pharmacotherapies?
- New report provides Rheumatoid Arthritis market insight

